The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.099
Bid: 0.096
Ask: 0.102
Change: 0.00 (0.00%)
Spread: 0.006 (6.25%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.099
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £400,000

19 Jan 2024 07:00

RNS Number : 2199A
Versarien PLC
19 January 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

19 January 2024

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £400,000

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £400,000 (before expenses) by way of a placing (the "Placing") of 500,000,000 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 0.08 pence per share (the "Placing Price").

 

Highlights

 

· Versarien has raised £400,000, before expenses, through the placing of 500,000,000 new ordinary shares in the capital of the Company at a price of 0.08 pence per share

· The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline whilst continuing to progress its asset sales

· The issue of the Placing Shares is within existing authorities granted by shareholders at the general meeting of the Company held on 10 January 2024 and therefore no shareholder approval is required for the Placing

 

Use of Proceeds and Turnaround Strategy

 

The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline. Recent new projects include a sales agreement with Go To Gym to bring Graphene-WearTM products to Colombia, Brazil and the USA, and Versarien's subsidiary, Gnanomat, entering into an agreement to co-develop advanced materials with IRPC, a Thai petroleum and petrochemical company. These projects, along with a pipeline of other opportunities currently being pursued demonstrate the longer term prospects for the business.

 

As announced on 20 December 2023, the mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020 continue to be marketed for sale and the Company is progressing discussions with a number of interested parties, though the timing of any asset sales and the quantum of the funds that may be received remains uncertain.

 

Stephen Hodge, Chief Executive Officer of Versarien, commented:

 

"In the short time since the Company Update announced on 20 December, the commercial, licencing and grant opportunities have continued to grow. This further funding will help us to progress the conversion of these leads while the asset sale discussions continue. We look forward to updating the market in due course."

 

Admission and Total Voting Rights

 

Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 24 January 2024. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 996,169,507. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGPUGWGUPCPGR
Date   Source Headline
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:35 pmRNSPrice Monitoring Extension
2nd Nov 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202212:48 pmRNSResult of AGM
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSBiaBrazil to utilise Graphene-Wear Technology
24th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSVerified Graphene Producer Re-certification
27th Jun 20227:00 amRNSLaunch of New Superparamagnetic Material
12th May 20227:00 amRNSInterim Results
10th May 20227:00 amRNSUmbro to Utilise Versarien’s Graphene-Wear Tech
3rd May 20227:00 amRNSNotice of Results and Investor Presentation
25th Apr 20223:25 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSLaunch of Lunar 3D printed lifestyle pods
24th Feb 20227:00 amRNSChange of Auditors and Accounting Reference Date
22nd Feb 20227:00 amRNSFlux Footwear to launch graphene enhanced shoe
20th Jan 20227:00 amRNSInvestor Event
4th Jan 20227:00 amRNSConfirmation of Board Change
24th Dec 20217:00 amRNSHolding(s) in Company
10th Dec 20217:00 amRNSInvestor Presentation
6th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSNotice of Results and Investor Presentation
17th Nov 20212:27 pmRNSHolding(s) in Company
16th Nov 202112:31 pmRNSSuperdry partners with Versarien
11th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSConsortium wins Department for Transport backing
29th Oct 20211:41 pmRNSResponse to Media Speculation
29th Oct 20217:00 amRNSInvestor Presentation
13th Oct 20217:00 amRNSAppointment of Non-executive Chairman
23rd Sep 20212:08 pmRNSResult of AGM
2nd Sep 202111:01 amRNSChange of Registered Address
27th Aug 20211:54 pmRNSNotice of AGM and Posting of Annual Report
11th Aug 20219:53 amRNSHolding(s) in Company
5th Aug 20217:00 amRNSPreliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20217:00 amRNS£1.93m strategic investment by Graphene Lab
26th Feb 202110:16 amRNSInnovate UK Loan
9th Feb 20217:00 amRNSGraphene Enhanced Mask Update
22nd Jan 202111:05 amRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSInterim Results
7th Jan 20217:00 amRNSAppointment of Chief Technology Officer
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSHolding(s) in Company
23rd Dec 202012:31 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSAcquisition, Subscription & Sharing Agreement
24th Nov 20207:00 amRNS£1.95 million Development Agreement
23rd Nov 20204:39 pmRNSInterim Results Reporting Extension
18th Nov 20207:00 amRNSSARS-CoV-2 Inhibition by Graphene / Metal Oxides
21st Oct 202012:00 pmRNSResult of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.